136 related articles for article (PubMed ID: 33993564)
1. Xeroderma Pigmentosum group D suppresses proliferation and promotes apoptosis of HepG2 cells by downregulating ERG expression via the PPARγ pathway.
He Y; Tao W; Shang C; Qi C; Ji D; Lu W; Chen G
Int J Exp Pathol; 2021 Jun; 102(3):157-162. PubMed ID: 33993564
[TBL] [Abstract][Full Text] [Related]
2. XPD could suppress growth of HepG2.2.15 and down-regulate the expression of hepatitis B virus x protein through P53 pathway.
Ding H; Xu JJ; Huang Y; Du FT; Zhang JX
Biochem Biophys Res Commun; 2012 Mar; 419(4):761-7. PubMed ID: 22387547
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of regulation of hepatoma cell cycle by XPD/P44 subcomplex : an in vitro experiment].
Wang HY; Xiong GF; Wu BL; Zhang JX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1997-2001. PubMed ID: 19062744
[TBL] [Abstract][Full Text] [Related]
4. Silencing of Xeroderma Pigmentosum Group D Gene Promotes Hepatoma Cell Growth by Reducing P53 Expression.
Ding H; Wen Z; Sun G
Med Sci Monit; 2018 Nov; 24():8015-8021. PubMed ID: 30409962
[TBL] [Abstract][Full Text] [Related]
5. COL4A1, negatively regulated by XPD and miR-29a-3p, promotes cell proliferation, migration, invasion and epithelial-mesenchymal transition in liver cancer cells.
Zhang H; Wang Y; Ding H
Clin Transl Oncol; 2021 Oct; 23(10):2078-2089. PubMed ID: 33891266
[TBL] [Abstract][Full Text] [Related]
6. XPD Functions as a Tumor Suppressor and Dysregulates Autophagy in Cultured HepG2 Cells.
Zheng JF; Li LL; Lu J; Yan K; Guo WH; Zhang JX
Med Sci Monit; 2015 May; 21():1562-8. PubMed ID: 26031757
[TBL] [Abstract][Full Text] [Related]
7. The role of XPD in cell apoptosis and viability and its relationship with p53 and cdk2 in hepatoma cells.
Wang HY; Xiong GF; Zhang JX; Xu H; Guo WH; Xu JJ; Xiong XY
Med Oncol; 2012 Mar; 29(1):161-7. PubMed ID: 21264535
[TBL] [Abstract][Full Text] [Related]
8. Xeroderma Pigmentosum Group D (XPD) Inhibits the Proliferation Cycle of Vascular Smooth Muscle Cell (VSMC) by Activating Glycogen Synthase Kinase 3β (GSK3β).
Li Q; Liao C; Xu W; Li G; Hong K; Cheng X; Li J
Med Sci Monit; 2018 Aug; 24():5951-5959. PubMed ID: 30146633
[TBL] [Abstract][Full Text] [Related]
9. Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression.
Cao LQ; Shao ZL; Liang HH; Zhang DW; Yang XW; Jiang XF; Xue P
Cancer Lett; 2015 Apr; 359(1):127-35. PubMed ID: 25592041
[TBL] [Abstract][Full Text] [Related]
10. Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma.
Vara D; Morell C; Rodríguez-Henche N; Diaz-Laviada I
Cell Death Dis; 2013 May; 4(5):e618. PubMed ID: 23640460
[TBL] [Abstract][Full Text] [Related]
11. MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor γ.
Li S; Li J; Fei BY; Shao D; Pan Y; Mo ZH; Sun BZ; Zhang D; Zheng X; Zhang M; Zhang XW; Chen L
Chin Med J (Engl); 2015 Apr; 128(7):941-7. PubMed ID: 25836616
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of PPARγ at Ser84 promotes glycolysis and cell proliferation in hepatocellular carcinoma by targeting PFKFB4.
Shu Y; Lu Y; Pang X; Zheng W; Huang Y; Li J; Ji J; Zhang C; Shen P
Oncotarget; 2016 Nov; 7(47):76984-76994. PubMed ID: 27769068
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-145 inhibits proliferation and promotes apoptosis of HepG2 cells by targeting ROCK1 through the ROCK1/NF-κB signaling pathway.
Wang RK; Shao XM; Yang JP; Yan HL; Shao Y
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2777-2785. PubMed ID: 31002128
[TBL] [Abstract][Full Text] [Related]
14. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
Xu Q; Cai W; Zhang M; Liu Q; Liu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
[TBL] [Abstract][Full Text] [Related]
15. Effect of silencing NEK2 on biological behaviors of HepG2 in human hepatoma cells and MAPK signal pathway.
Zhang MX; Xu XM; Zhang P; Han NN; Deng JJ; Yu TT; Gan YY; He XQ; Long ZX
Tumour Biol; 2016 Feb; 37(2):2023-35. PubMed ID: 26337275
[TBL] [Abstract][Full Text] [Related]
16. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-γ activation inhibits hepatocellular carcinoma cell invasion by upregulating plasminogen activator inhibitor-1.
Pang X; Wei Y; Zhang Y; Zhang M; Lu Y; Shen P
Cancer Sci; 2013 Jun; 104(6):672-80. PubMed ID: 23461356
[TBL] [Abstract][Full Text] [Related]
18. Involvement of PPARα and PPARγ in apoptosis and proliferation of human hepatocarcinoma HepG2 cells.
Maggiora M; Oraldi M; Muzio G; Canuto RA
Cell Biochem Funct; 2010 Oct; 28(7):571-7. PubMed ID: 20862655
[TBL] [Abstract][Full Text] [Related]
19. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.
Cheung KF; Zhao J; Hao Y; Li X; Lowe AW; Cheng AS; Sung JJ; Yu J
Cancer; 2013 Mar; 119(6):1217-26. PubMed ID: 23212831
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HOTAIRM1 inhibits the progression of hepatocellular carcinoma by inhibiting the Wnt signaling pathway.
Zhang Y; Mi L; Xuan Y; Gao C; Wang YH; Ming HX; Liu J
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4861-4868. PubMed ID: 30070317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
